Search Results for: lung cancer

Palliative care has been proven extremely effective in the treatment of cancer patients of all types, including those diagnosed with malignant mesothelioma. According to a new study, over the last several years the time between diagnosis and first use has decreased. That has resulted in lowered costs and improved survival in those who have utilized

In the face of a terminal illness, many patients seek alternative treatments, and this is as true for malignant mesothelioma as for any other type of intractable cancer. Some of the solutions being offered are little better than snake oil – witness the fruitless search for a miracle that actor Steve McQueen pursued when he

The use of state-of-the-art medications holds tremendous hope for patients diagnosed with malignant mesothelioma, but there are no sure things and no silver bullets. These new drugs have not been fully tested and can lead to deadly side effects. A recent report published by Australian researchers revealed that a patient treated with one of the

Malignant mesothelioma is known for many things, including the fact that it is notably resistant to traditional cancer treatments. Researchers are constantly working to find effective means of slowing the asbestos-related cancer’s spread and delaying the need for aggressive surgeries or toxic systemic therapies. A new study published in the journal Lung Cancer indicates that the use

Patients diagnosed with malignant mesothelioma face countless challenges, not the least of which is managing their symptoms without having to constantly leave their homes. While COVID-19 is the most recent and obvious hurdle, those who do not live near a major metropolitan hospital have long struggled with the same problem. According to a new study

The entire nation and much of the world has been affected by fear of COVID-19, but perhaps none are as concerned as those diagnosed with mesothelioma and other asbestos-related diseases. This population, with its scarred lungs and fragile health, knows that exposure to the virus could be a death sentence. Their concerns are in particularly

Malignant mesothelioma is so rare that it presents a challenge for many physicians. It is not uncommon for doctors never to have seen a patient with the disease and, if one is diagnosed, to be unfamiliar with the appropriate course of treatment. In response to this and to refresh available information for others, two researchers

When mesothelioma patients and their physicians discuss treatment plans, one of the most common topics is trade-offs. Almost every step forward in the status of their cancer might come at the cost of some other aspect of their health. One example is the kidney damage that often follows cisplatin-based chemotherapy treatment. But now Japanese researchers